Evaluation anti-hyperlipidemia effect of Pistacia atlantica Desf. ssp. Kurdica versus placebo in diabetic patients
Phase 2
Recruiting
- Conditions
- Hyperlipidemia.Hyperlipidaemia, unspecified
- Registration Number
- IRCT201708109014N178
- Lead Sponsor
- Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
Age of 18 to 65 years; hypercholesterolemia; HbA1C between 6 to 10.
Exclusion criteria: Renal disease; Liver disorder; gastric problem; heart failure; brain disease; sensitivity to Pistacia Atlantica Kurdica; insulin usage; myopathy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing serum cholesterol. Timepoint: before and 1 and 2 months after intervention. Method of measurement: through laboratory test.;Assessing blood sugar. Timepoint: before and 1 and 2 months after intervention. Method of measurement: through laboratory test.
- Secondary Outcome Measures
Name Time Method Assessing side effects including nausea and vomiting. Timepoint: 1 and 2 months after intervention. Method of measurement: through history taking.